Bladder (Urothelial, Transitional Cell) Cancer
Oncology·MeSH: Urologic Neoplasms
Prevalence
41.9 / 100K
Incidence
7.4 / 100K/yr
3 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Bladder (Urothelial, Transitional Cell) Cancer?
BioSniper tracks 3 drugs in development for Bladder (Urothelial, Transitional Cell) Cancer across 2 companies.
How many clinical trials target Bladder (Urothelial, Transitional Cell) Cancer?
There are 4 clinical trials targeting Bladder (Urothelial, Transitional Cell) Cancer tracked by BioSniper.
What is the prevalence of Bladder (Urothelial, Transitional Cell) Cancer?
The estimated prevalence of Bladder (Urothelial, Transitional Cell) Cancer is approximately 41.9 per 100,000 population.
Deep-dive into Bladder (Urothelial, Transitional Cell) Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis